NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
25/05/2022
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Tipo de processo
Eventos registrados
Atualização mais recente
Classificação
Tipo de marca
Classes Nice
Data de depósito
Data de registro
Data de expiração
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
Última transação
Escritório responsável
Código da situação
Cadastro oficial
Fundamento do pedido
Primeiro uso
Primeiro uso no comércio
Código do desenho
Tipo de titular
Localização do titular
Examinador
Unidade examinadora
Localização atual
Titulares
Representantes
Michele H. Bowman ABBOTT LABORATORIES
Classes Nice
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 9
Downloadable software and mobile applications for use in connection with infectious disease testing; downloadable software and mobile applications for infectious disease data and information management; downloadable software and mobile applications for use in the field of infectious disease testing; downloadable software and mobile applications for receiving, storing, displaying, tracking, sharing, reporting, maintaining, and managing infectious disease data and information
Classe 42
Online software services, cloud-based software services, software as a service (SAAS) services featuring computer software, and platform as a service (PAAS) services featuring computer software, for use in connection with infectious disease testing; online software services, cloud-based software services, software as a service (SAAS) services featuring computer software, and platform as a service (PAAS) services featuring computer software, for infectious disease data and information management; online software services, cloud-based software services, software as a service (SAAS) services featuring computer software, and platform as a service (PAAS) services featuring computer software, for use in the field of infectious disease testing; online software services, cloud-based software services, software as a service (SAAS) services featuring computer software, and platform as a service (PAAS) services featuring computer software, for receiving, storing, displaying, tracking, sharing, reporting, maintaining, managing, monitoring, and analyzing infectious disease data and information; educational online software services, cloud-based software services, software as a service (SAAS) services featuring computer software, and platform as a service (PAAS) services featuring computer software, in the field of infectious disease testing; online software services, cloud-based software services, software as a service (SAAS) services featuring computer software, and platform as a service (PAAS) services featuring computer software, for training in the field of infectious disease testing; providing Internet website portals and web-based software platforms for use in connection with infectious disease testing; providing Internet website portals and web-based software platforms for infectious disease data and information management; providing Internet website portals and web-based software platforms for use in the field of infectious disease testing; providing Internet website portals and web-based software platforms for receiving, storing, displaying, tracking, sharing, reporting, maintaining, managing, monitoring, and analyzing infectious disease data and information; providing educational Internet website portals and web-based software platforms in the field of infectious disease testing; providing Internet website training portals and web-based training platforms in the field of infectious disease testing
Histórico de despachos e eventos da marca no USPTO.
25 publicações encontradas
NOTICE OF REGISTRATION CONFIRMATION EMAILED
25/05/2022
REGISTERED-PRINCIPAL REGISTER
24/05/2022
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
22/04/2022
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
21/04/2022
STATEMENT OF USE PROCESSING COMPLETE
24/03/2022
CASE ASSIGNED TO INTENT TO USE PARALEGAL
23/03/2022
USE AMENDMENT FILED
25/02/2022
TEAS STATEMENT OF USE RECEIVED
25/02/2022
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
31/08/2021
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
19/07/2021
EXTENSION OF TIME TO OPPOSE RECEIVED
02/04/2021
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/03/2021
PUBLISHED FOR OPPOSITION
09/03/2021
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
17/02/2021
APPROVED FOR PUB - PRINCIPAL REGISTER
29/01/2021
EXAMINER'S AMENDMENT ENTERED
29/01/2021
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
29/01/2021
EXAMINERS AMENDMENT E-MAILED
29/01/2021
EXAMINERS AMENDMENT -WRITTEN
29/01/2021
PREVIOUS ALLOWANCE COUNT WITHDRAWN
09/01/2021
WITHDRAWN FROM PUB - OG REVIEW QUERY
15/12/2020
APPROVED FOR PUB - PRINCIPAL REGISTER
03/12/2020
ASSIGNED TO EXAMINER
01/12/2020
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
17/09/2020
NEW APPLICATION ENTERED
18/08/2020
Proteção contínua da sua marca
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.